Cite
HARVARD Citation
Shen, M. et al. (2021). At least two high-risk cytogenetic abnormalities indicate the inferior outcomes for newly diagnosed multiple myeloma patients: a real-world study in China. Leukemia & lymphoma. 62 (12), pp. 2992-3001. [Online].